This contrasts with reports suggesting that elevated ORM1 expression correlates with chemotherapy resistance and increased metastasis in certain solid tumors, such as breast cancer and hepatocellular carcinoma, highlighting how the role of a protein can vary across different malignancies [74,75]. Here, ORM1 is linked to breast carcinoma.